Role of Polyamines as Biomarkers in Lymphoma Patients: A Pilot Study

Lymphomas represent a heterogeneous and widely diversified group of neoplastic diseases rising from a variety of lymphoid subsets at heterogeneous differentiation stages. These lymphoproliferative disorders lead to the clinicopathological complexity of the classification of lymphoid neoplasms, describing to date more than 40 categories of non-Hodgkin’s lymphoma (NHL) and 5 categories of Hodgkin’s lymphoma (HL). Inflammation has been shown to play a key role in the evolution of cancer diseases, and it might be interesting to understand their role also in the context of lymphoid neoplasms. Among circulating biomarkers, the role of polyamines belonging to the arginine and lysine metabolism is relevant. Through modern analytical methods, such as mass spectrometry (MS), we are enabled to increase knowledge and improve our understanding of cancer metabolism. In this study, high-resolution mass spectrometry was used in combination with high-performance liquid chromatography (LC-HRMS) to measure serum levels of polyamines and identify possible diagnostic circulating biomarkers, potentially allowing a more accurate assessment of the diagnostic stratification of lymphoma patients and robust comparisons between different patient groups.

[1]  N. Culeddu,et al.  Plasma Polyamine Biomarker Panels: Agmatine in Support of Prostate Cancer Diagnosis , 2022, Biomolecules.

[2]  O. Fiehn,et al.  Polyamine Metabolites as Biomarkers in Head and Neck Cancer Biofluids , 2022, Diagnostics.

[3]  P. Dey,et al.  Fine-Needle Aspiration Diagnosis of Lymphoma Based on Cytomorphology Alone: How Accurate is it? - A Cyto-Histopathology Correlative Study , 2021, Journal of Cytology.

[4]  G. Docimo,et al.  Clinical significance of neutrophil-to-lymphocyte ratio, lymphocyte-to-monocyte ratio, platelet-to-lymphocyte ratio and prognostic nutritional index in low-risk differentiated thyroid carcinoma , 2021, Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale.

[5]  T. Solinas,et al.  A preliminary study procedure for detection of polyamines in plasma samples as a potential diagnostic tool in prostate cancer. , 2020, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[6]  Yuxin Sun,et al.  Polyamines and related signaling pathways in cancer , 2020, Cancer cell international.

[7]  Yongfeng Ding,et al.  Prognostic Value of Neutrophil–Lymphocyte Ratio, Platelet–Lymphocyte Ratio, and Combined Neutrophil–Lymphocyte Ratio and Platelet–Lymphocyte Ratio in Stage IV Advanced Gastric Cancer , 2020, Frontiers in Oncology.

[8]  X. Ju,et al.  A Novel Prognostic Marker Systemic Inflammation Response Index (SIRI) for Operable Cervical Cancer Patients , 2020, Frontiers in Oncology.

[9]  M. Podhorecka,et al.  The Neutrophil to Lymphocyte and Lymphocyte to Monocyte Ratios as New Prognostic Factors in Hematological Malignancies – A Narrative Review , 2020, Cancer management and research.

[10]  Shehua Qian,et al.  Chronic inflammation: key player and biomarker-set to predict and prevent cancer development and progression based on individualized patient profiles , 2019, EPMA Journal.

[11]  Ashish Kumar,et al.  Challenges and Opportunities in Cancer Metabolomics , 2019, Proteomics.

[12]  G. Hoefler,et al.  Tumor Macroenvironment: An Update , 2019, Pathobiology.

[13]  A. Dogan,et al.  Prognostic and Predictive Biomarkers in Diffuse Large B-cell Lymphoma. , 2019, Surgical pathology clinics.

[14]  A. Pegg,et al.  Polyamine metabolism and cancer: treatments, challenges and opportunities , 2018, Nature Reviews Cancer.

[15]  Yu Hu,et al.  Prognostic role of neutrophil-to-lymphocyte ratio in diffuse large B cell lymphoma patients: an updated dose–response meta-analysis , 2018, Cancer cell international.

[16]  Andrea Bellincontro,et al.  Partial least squares discriminant analysis: A dimensionality reduction method to classify hyperspectral data , 2018, 1806.09347.

[17]  C. Carru,et al.  Blood cell count indexes as predictors of outcomes in advanced non-small-cell lung cancer patients treated with Nivolumab , 2018, Cancer Immunology and Immunotherapy.

[18]  T. Lehtimäki,et al.  Altered Polyamine Profiles in Colorectal Cancer , 2018, AntiCancer Research.

[19]  C. Vetro,et al.  Prognostic meaning of neutrophil to lymphocyte ratio (NLR) and lymphocyte to monocyte ration (LMR) in newly diagnosed Hodgkin lymphoma patients treated upfront with a PET-2 based strategy , 2018, Annals of Hematology.

[20]  Yu Hu,et al.  Prognostic and clinicopathological significance of long noncoding RNA HOXA11-AS expression in human solid tumors: a meta-analysis , 2018, Cancer Cell International.

[21]  J. Cui,et al.  Value of neutrophil-to-lymphocyte ratio for predicting lung cancer prognosis: A meta-analysis of 7,219 patients. , 2017, Molecular and clinical oncology.

[22]  Chih-Chiang Tsou,et al.  Functional proteogenomics reveals biomarkers and therapeutic targets in lymphomas , 2017, Proceedings of the National Academy of Sciences.

[23]  Meijuan Huang,et al.  The Enhanced International Prognostic Index for Diffuse Large B‐cell Lymphoma , 2017, The American journal of the medical sciences.

[24]  A. Pegg.  Functions of Polyamines in Mammals* , 2016, The Journal of Biological Chemistry.

[25]  S. Tsakovski,et al.  Comparison of the variable importance in projection (VIP) and of the selectivity ratio (SR) methods for variable selection and interpretation , 2015 .

[26]  Huining Kang,et al.  A retrospective study to assess the relative value of peripheral blood, bone marrow aspirate and biopsy morphology, immunohistochemical stains, and flow cytometric analysis in the diagnosis of chronic B cell lymphoproliferative neoplasms , 2015, International Journal of Laboratory Hematology.

[27]  T. Witzig,et al.  Prognostic factors for diffuse large B-cell lymphoma in the R(X)CHOP era. , 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

[28]  Huarong Xu,et al.  Determination of polyamine metabolome in plasma and urine by ultrahigh performance liquid chromatography-tandem mass spectrometry method: application to identify potential markers for human hepatic cancer. , 2013, Analytica chimica acta.

[29]  G. Siuzdak,et al.  Innovation: Metabolomics: the apogee of the omics trilogy , 2012, Nature Reviews Molecular Cell Biology.

[30]  L. Cantley,et al.  Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation , 2009, Science.

[31]  Age K. Smilde,et al.  UvA-DARE ( Digital Academic Repository ) Assessment of PLSDA cross validation , 2008 .

[32]  Wen-Qi Jiang,et al.  High incidence of hepatitis B virus infection in B‐cell subtype non‐Hodgkin lymphoma compared with other cancers , 2007, Cancer.

[33]  A. Gugliucci.  Polyamines as clinical laboratory tools. , 2004, Clinica chimica acta; international journal of clinical chemistry.

[34]  Knut Baumann,et al.  Cross-validation as the objective function for variable-selection techniques , 2003 .

[35]  K. Kashiwagi,et al.  Polyamines: mysterious modulators of cellular functions. , 2000, Biochemical and biophysical research communications.

[36]  O. Warburg.  [Origin of cancer cells]. , 1956, Oncologia.

[37]  Ralf Küppers,et al.  The biology of Hodgkin's lymphoma , 2009, Nature Reviews Cancer.

[38]  Huifang M. Zhang,et al.  Polyamine-modulated expression of c-myc plays a critical role in stimulation of normal intestinal epithelial cell proliferation. , 2005, American journal of physiology. Cell physiology.